Procter & Gamble Health reports Q4 sales at Rs. 277 Cr
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients
The emergence of new infections in India is a growing concern
The partnership marks a significant milestone in integrating digital health education into medical curricula
This project is supported by the Irish Government through IDA Ireland
The comprehensive criteria encompasses evaluation of debt management, sales growth, earnings-per-share performance, as well as returns on equity
Research & Development (R&D) investments for the quarter stood at Rs. 392.5 crore which is 6.3% of its revenues
Subscribe To Our Newsletter & Stay Updated